Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-26

Clinical Trial Update: Anti-viral Effects of Azithromycin in Patients With Asthma and COPD [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigates the anti-viral effects of azithromycin in patients with asthma and chronic obstructive pulmonary disease (COPD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)

Snippet

Sponsor: Bispebjerg Hospital | Conditions: Asthma, COPD | Phase 4 | Status: UNKNOWN